FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794334178> ?p ?o ?g. }

• W2794334178 endingPage "1325" @default.
• W2794334178 startingPage "1318" @default.
• W2794334178 abstract "Background Glucagon-like peptide 1 (GLP-1) analogs administered before or after cerebral ischemia have been shown to provide neuroprotection. Here, we explored whether delayed administration of a GLP-1 analog, liraglutide, could improve long-term functional recovery and promote angiogenesis after stroke. Materials and Methods In the present study, mice were established as a focal cerebral cortical ischemia model and were intraperitoneally administered liraglutide or normal saline (NS) daily for 14 consecutive days, starting 1 day after cerebral ischemia. The neurological deficits were evaluated using rotarod test. The microvessel density (MVD) and endothelial cell (EC) proliferation were assessed by immunohistochemical staining. The expression of vascular endothelial growth factor (VEGF) was assessed by Western blot analysis. Results Liraglutide significantly reduced infarct volume and improved the rotarod test scores, compared with mice treated with NS. Liraglutide also greatly increased the MVD and EC proliferation and simultaneously upregulated the expression of VEGF in the cerebral ischemic area. Conclusions These results demonstrated that liraglutide promoted angiogenesis and long-term recovery of cerebral ischemia through increasing the expression of VEGF. Glucagon-like peptide 1 (GLP-1) analogs administered before or after cerebral ischemia have been shown to provide neuroprotection. Here, we explored whether delayed administration of a GLP-1 analog, liraglutide, could improve long-term functional recovery and promote angiogenesis after stroke. In the present study, mice were established as a focal cerebral cortical ischemia model and were intraperitoneally administered liraglutide or normal saline (NS) daily for 14 consecutive days, starting 1 day after cerebral ischemia. The neurological deficits were evaluated using rotarod test. The microvessel density (MVD) and endothelial cell (EC) proliferation were assessed by immunohistochemical staining. The expression of vascular endothelial growth factor (VEGF) was assessed by Western blot analysis. Liraglutide significantly reduced infarct volume and improved the rotarod test scores, compared with mice treated with NS. Liraglutide also greatly increased the MVD and EC proliferation and simultaneously upregulated the expression of VEGF in the cerebral ischemic area. These results demonstrated that liraglutide promoted angiogenesis and long-term recovery of cerebral ischemia through increasing the expression of VEGF." @default.
• W2794334178 created "2018-03-29" @default.
• W2794334178 creator A5039372448 @default.
• W2794334178 creator A5046323357 @default.
• W2794334178 creator A5049692788 @default.
• W2794334178 creator A5065118789 @default.
• W2794334178 creator A5077128913 @default.
• W2794334178 date "2018-05-01" @default.
• W2794334178 modified "2023-10-14" @default.
• W2794334178 title "Delayed Administration of the Glucagon-Like Peptide 1 Analog Liraglutide Promoting Angiogenesis after Focal Cerebral Ischemia in Mice" @default.
• W2794334178 cites W1147678966 @default.
• W2794334178 cites W1964210744 @default.
• W2794334178 cites W1970165453 @default.
• W2794334178 cites W1982275907 @default.
• W2794334178 cites W1983763042 @default.
• W2794334178 cites W1989453119 @default.
• W2794334178 cites W1995209325 @default.
• W2794334178 cites W1997653546 @default.
• W2794334178 cites W2007313337 @default.
• W2794334178 cites W2008337869 @default.
• W2794334178 cites W2011601530 @default.
• W2794334178 cites W2017518223 @default.
• W2794334178 cites W2021612766 @default.
• W2794334178 cites W2029366332 @default.
• W2794334178 cites W2032196626 @default.
• W2794334178 cites W2038108333 @default.
• W2794334178 cites W2043673143 @default.
• W2794334178 cites W2045846363 @default.
• W2794334178 cites W2062594120 @default.
• W2794334178 cites W2066406526 @default.
• W2794334178 cites W2088190876 @default.
• W2794334178 cites W2094706071 @default.
• W2794334178 cites W2097159083 @default.
• W2794334178 cites W2110823032 @default.
• W2794334178 cites W2112095855 @default.
• W2794334178 cites W2122356899 @default.
• W2794334178 cites W2125683177 @default.
• W2794334178 cites W2129081519 @default.
• W2794334178 cites W2140562862 @default.
• W2794334178 cites W2145185779 @default.
• W2794334178 cites W2145377160 @default.
• W2794334178 cites W2153878657 @default.
• W2794334178 cites W2175065114 @default.
• W2794334178 cites W2181446747 @default.
• W2794334178 cites W2221406620 @default.
• W2794334178 cites W2270971263 @default.
• W2794334178 cites W2301822706 @default.
• W2794334178 cites W2443300690 @default.
• W2794334178 cites W2744119474 @default.
• W2794334178 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.12.015" @default.
• W2794334178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29395648" @default.
• W2794334178 hasPublicationYear "2018" @default.
• W2794334178 type Work @default.
• W2794334178 sameAs 2794334178 @default.
• W2794334178 citedByCount "22" @default.
• W2794334178 countsByYear W27943341782018 @default.
• W2794334178 countsByYear W27943341782019 @default.
• W2794334178 countsByYear W27943341782020 @default.
• W2794334178 countsByYear W27943341782021 @default.
• W2794334178 countsByYear W27943341782022 @default.
• W2794334178 countsByYear W27943341782023 @default.
• W2794334178 crossrefType "journal-article" @default.
• W2794334178 hasAuthorship W2794334178A5039372448 @default.
• W2794334178 hasAuthorship W2794334178A5046323357 @default.
• W2794334178 hasAuthorship W2794334178A5049692788 @default.
• W2794334178 hasAuthorship W2794334178A5065118789 @default.
• W2794334178 hasAuthorship W2794334178A5077128913 @default.
• W2794334178 hasConcept C126322002 @default.
• W2794334178 hasConcept C127413603 @default.
• W2794334178 hasConcept C134018914 @default.
• W2794334178 hasConcept C167734588 @default.
• W2794334178 hasConcept C25498285 @default.
• W2794334178 hasConcept C2777025900 @default.
• W2794334178 hasConcept C2777180221 @default.
• W2794334178 hasConcept C2778820722 @default.
• W2794334178 hasConcept C2780394083 @default.
• W2794334178 hasConcept C2780645631 @default.
• W2794334178 hasConcept C2781308992 @default.
• W2794334178 hasConcept C541997718 @default.
• W2794334178 hasConcept C555293320 @default.
• W2794334178 hasConcept C71924100 @default.
• W2794334178 hasConcept C78519656 @default.
• W2794334178 hasConcept C98274493 @default.
• W2794334178 hasConceptScore W2794334178C126322002 @default.
• W2794334178 hasConceptScore W2794334178C127413603 @default.
• W2794334178 hasConceptScore W2794334178C134018914 @default.
• W2794334178 hasConceptScore W2794334178C167734588 @default.
• W2794334178 hasConceptScore W2794334178C25498285 @default.
• W2794334178 hasConceptScore W2794334178C2777025900 @default.
• W2794334178 hasConceptScore W2794334178C2777180221 @default.
• W2794334178 hasConceptScore W2794334178C2778820722 @default.
• W2794334178 hasConceptScore W2794334178C2780394083 @default.
• W2794334178 hasConceptScore W2794334178C2780645631 @default.
• W2794334178 hasConceptScore W2794334178C2781308992 @default.
• W2794334178 hasConceptScore W2794334178C541997718 @default.
• W2794334178 hasConceptScore W2794334178C555293320 @default.
• W2794334178 hasConceptScore W2794334178C71924100 @default.
• W2794334178 hasConceptScore W2794334178C78519656 @default.

• next